Marika Alborghetti

428 total citations
28 papers, 266 citations indexed

About

Marika Alborghetti is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marika Alborghetti has authored 28 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 10 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marika Alborghetti's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers) and Balance, Gait, and Falls Prevention (4 papers). Marika Alborghetti is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers) and Balance, Gait, and Falls Prevention (4 papers). Marika Alborghetti collaborates with scholars based in Italy, France and Germany. Marika Alborghetti's co-authors include Ferdinando Nicoletti, Francesco E. Pontieri, Edoardo Bianchini, Domiziana Rinaldi, Silvia Galli, Gaia Romana Pellicano, Clelia Pellicano, Francesca Assogna, Carlo Caltagirone and Gianfranco Spalletta and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Sensors.

In The Last Decade

Marika Alborghetti

23 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marika Alborghetti Italy 8 155 50 43 36 36 28 266
Bruno Lopes Santos‐Lobato Brazil 10 131 0.8× 53 1.1× 50 1.2× 28 0.8× 14 0.4× 37 246
Federico Carbone Austria 7 164 1.1× 59 1.2× 20 0.5× 22 0.6× 64 1.8× 13 279
Katarina Rukavina United Kingdom 10 297 1.9× 60 1.2× 22 0.5× 20 0.6× 21 0.6× 23 374
Nelson Lo United Kingdom 4 208 1.3× 125 2.5× 28 0.7× 32 0.9× 13 0.4× 7 309
Ariane Park United States 7 252 1.6× 71 1.4× 82 1.9× 44 1.2× 8 0.2× 8 379
Silvia Ríos‐Romenets Colombia 5 155 1.0× 46 0.9× 27 0.6× 28 0.8× 9 0.3× 9 221
Vibhash D. Sharma United States 11 248 1.6× 96 1.9× 40 0.9× 18 0.5× 11 0.3× 33 370
Nicole Neilson Canada 7 200 1.3× 64 1.3× 49 1.1× 20 0.6× 7 0.2× 7 278
Francesco Nicoletti Italy 6 121 0.8× 55 1.1× 65 1.5× 34 0.9× 20 0.6× 11 318
A. Castro Spain 8 194 1.3× 54 1.1× 28 0.7× 14 0.4× 9 0.3× 13 236

Countries citing papers authored by Marika Alborghetti

Since Specialization
Citations

This map shows the geographic impact of Marika Alborghetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marika Alborghetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marika Alborghetti more than expected).

Fields of papers citing papers by Marika Alborghetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marika Alborghetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marika Alborghetti. The network helps show where Marika Alborghetti may publish in the future.

Co-authorship network of co-authors of Marika Alborghetti

This figure shows the co-authorship network connecting the top 25 collaborators of Marika Alborghetti. A scholar is included among the top collaborators of Marika Alborghetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marika Alborghetti. Marika Alborghetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alborghetti, Marika, María Antonietta Barbieri, Ferdinando Nicoletti, & Edoardo Spina. (2025). Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders. Expert Opinion on Drug Metabolism & Toxicology. 21(10). 1169–1193.
2.
3.
Kotzalidis, Georgios D., Luana Lionetto, E. Serra, et al.. (2025). Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels. International Journal of Molecular Sciences. 26(3). 1394–1394. 3 indexed citations
4.
Stocchi, Fabrizio, et al.. (2025). Dysphagia and oropharyngeal bradykinesia in Parkinson's disease. Journal of Neural Transmission. 132(11). 1665–1671.
5.
Bianchini, Edoardo, Domiziana Rinaldi, S. Galli, et al.. (2025). Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study. JMIR Formative Research. 9. e63153–e63153. 1 indexed citations
6.
Alborghetti, Marika, et al.. (2025). Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson’s disease. npj Parkinson s Disease. 11(1). 290–290.
7.
Bianchini, Edoardo, et al.. (2024). The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease. Brain Sciences. 14(1). 109–109. 7 indexed citations
8.
Galli, Silvia, Edoardo Bianchini, Marika Alborghetti, et al.. (2024). Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review. Clinical Autonomic Research. 35(2). 159–182. 2 indexed citations
9.
10.
Bianchini, Edoardo, S. Galli, Marika Alborghetti, et al.. (2023). Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch. Sensors. 23(21). 8971–8971. 10 indexed citations
11.
Alborghetti, Marika, et al.. (2023). Type-B monoamine oxidase inhibitors in neurological diseases. Neural Regeneration Research. 19(1). 16–21. 27 indexed citations
12.
Alborghetti, Marika, et al.. (2023). Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia. Schizophrenia Bulletin. 50(2). 374–381. 7 indexed citations
13.
14.
Menna, Luisa Di, Rosamaria Orlando, C. Bonaccorso, et al.. (2023). Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism. Neuropharmacology. 238. 109642–109642. 3 indexed citations
15.
16.
Bianchini, Edoardo, Marika Alborghetti, Domiziana Rinaldi, et al.. (2022). Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease. Frontiers in Neurology. 13. 909197–909197. 25 indexed citations
17.
Menna, Luisa Di, Carla L. Busceti, Rosamaria Orlando, et al.. (2021). The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice. Pharmacological Research. 170. 105691–105691. 4 indexed citations
18.
Bianchini, Edoardo, et al.. (2021). Validation of the Canadian Occupational Performance Measure in Italian Parkinson’s Disease Clients. Physical & Occupational Therapy In Geriatrics. 40(1). 26–37. 4 indexed citations
19.
Bianchini, Edoardo, et al.. (2021). Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients: a retrospective, pilot study. Neurological Research. 43(11). 950–954. 9 indexed citations
20.
Rinaldi, Domiziana, Edoardo Bianchini, Marika Alborghetti, et al.. (2020). The tolerability, safety and efficacy of safinamide in elderly Parkinson’s disease patients: a retrospective study. Aging Clinical and Experimental Research. 33(6). 1689–1692. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Lopes Santos‐Lobato Breakdown of academic impact, for papers by Federico Carbone Breakdown of academic impact, for papers by Katarina Rukavina Breakdown of academic impact, for papers by Nelson Lo Breakdown of academic impact, for papers by Ariane Park Breakdown of academic impact, for papers by Silvia Ríos‐Romenets Breakdown of academic impact, for papers by Vibhash D. Sharma Breakdown of academic impact, for papers by Nicole Neilson Breakdown of academic impact, for papers by Francesco Nicoletti Breakdown of academic impact, for papers by A. Castro
Rankless by CCL
2026